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Abstract
Introduction: Ischemic mitral regurgitation (MR) is a common com-
plication of acute myocardial infarction and has a negative impact on 
prognosis. However, few studies have been carried out on MR after 
non-ST-segment elevation acute myocardial infarction (NSTEMI).
Aim: Investigate the clinical predictors of ischemic MR and its impact 
on the outcome after 1st NSTEMI.
Methods: 40 consecutive patients were selected after a first NS-
TEMI. Each underwent echocardiography and coronary angiogra-
phy during their hospital admission. Patients were divided into two 
groups according to the presence or absence of MR at echocardio-
graphy: Group I: 20 patients without MR, Group II: 20 patients with 
MR. The patients were followed up clinically for at least one year. 
The incidence of readmission for heart failure, unstable angina, rein-
farction, or all combined (i.e, major adverse cardiac event [MACE]) 
was recorded.
Results: The patients’ mean age was 59.62±10.97 years and 67.5 
% were male. They were followed–up for a median of 640.5 days. 
No significant differences between both groups regarding baseline 
data, cardiac isoenzymes, or revascularization (P > 0.05), but there 
was significantly increased number of diseased coronary arteries in 
MR group (P 0.04). LA diameter was significantly increased with de-
creased LVEF% and increased wall motion abnormalities in MR group 
((P < 0.05). During follow-up period, more admissions for unstable 
angina were seen in patients with MR but with little significance (P 
0.05). Regarding MACE, a greater incidence was found in the MR 
group (P < 0.05). Using Kaplan-Meier curves, a long-term association 
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About this subject
It is well known through many studies the adver-
se prognosis of ischemic MR after acute coronary 
syndrome specially STEMI and just scarce studies 
address that effect after NSTEMI. We think that our 
study is the only one to choose patients documen-
ted to had no MR before NSTEMI.
This will add the importance to strongly handle 
any MR after acute coronary syndrome with careful 
attention to help decision making.
Introduction
Ischemic mitral regurgitation (MR) conveys adver-
se prognosis, doubling mortality after myocardial 
infarction (MI), in chronic heart failure, and after 
surgical or catheter revascularization [1, 2].
Not only patients with moderate to severe MR 
had a greater risk of mortality and worse prognosis 
[3] but also mildest grades of MR were associated 
with worse prognosis [4, 5] with a graded relation-
ship between severity and reduced survival [6].
In fact, MR after MI was associated with a 3-fold 
increased risk of heart failure, regardless of age, 
sex, Killip class at admission, and ejection fraction 
[7]. Also, it has been reported that degenerative 
MR before infarction is an independent risk factor 
[8].
In general, previous studies have focused on ST-
elevation myocardial infarction, during the short or 
medium term and ischemic MR [1, 4]. Few studies 
have addressed the role of functional MR in risk 
stratification in patients with NSTEMI during the 
long- term and even the short- term [9, 10, 11]. 
Thus, we aimed to investigate the clinical predic-
tors of ischemic MR and its impact on the outcome 
after 1st NSTEMI. 
Patients and methods
A total of 40 consecutive patients who mets the 
criteria of the study protocol were selected.
Inclusion criteria
-  Admission to the coronary unit of our center 
for a first NSTEMI. 
-  All patients were scheduled for coronary angio-
graphy during their hospital admittion.
-  Available echo-Doppler report before admis-
sion with no evidence for MR.
-  Regular periodic follow-up for at least 1 year.
Exclusion criteria
-  Valvular structural heart disease, mitral pros-
thesis. 
-  Hypertrophic cardiomyopathy. 
-  NYHA functional class III or IV.
-  AF or kidney failure.
-  Mechanical complications. 
-  Poor ultrasound window. 
The diagnosis of NSTEMI was based on the cri-
teria published by the European Society of Cardio-
logy [12]. The medical record, laboratory findings, 
hospital course, and follow-up were meticulously 
collected.
of MACE with the presence of MR was found (P 0.04), and a higher 
grades of MR were associated with poor prognosis (P 0.05).
In conclusion: Ischemic MR yield poor prognosis. Thus, current 
MR should be carefully assessed after NSTEMI, and probably requi-
res even more meticulous treatment including early revascularization 
and stricter follow-up than usual.
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Echocardiographic studies
All patients underwent complete echo-Doppler 
evaluation within the 1st 3 days of admission. The 
machine used was GE Vivid 7 ultrasound system 
with 2.5 MHz transducer. Images were taken while 
the patient supine or in the left lateral position, 
utilizing the two-dimensional (2-D), M-mode and 
Doppler echocardiographic techniques. Measure-
ments included left atrial and ventricular diameters 
measured in the M-mode; left parasternal view. 
Left ventricular ejection fraction was calculated in 
2D-mode, in the apical 2- and 4- chamber apical 
views, using the Simpson biplane method. Left 
ventricular regional systolic function was assessed 
by dividing the left ventricle into the 16-segment 
model, following the recommendations of the 
American Society of Echocardiography [13]. Wall 
motion for each segment was visually graded using 
both endocardial motion and wall thickness with 
a semiquantitative four-points scoring system. The 
sum of these individual segmental scores is divided 
by the total number of the interpretable 16 seg-
ments to obtain the total wall motion score index. 
Systolic pulmonary artery pressure was calculated 
in reference to tricuspid regurgitation [14].
Mitral valve anatomy and function were specifica-
lly studied. Mitral regurgitation and its grade were 
assessed using the color jet area, vena contracta 
width (VCW), and the proximal isovelocity surface 
area (PISA) method, as usually conducted in our la-
boratory. PISA method, validated and simplified, is 
in excellent agreement with the angiographic grade 
of mitral regurgitation [15, 16].
Thus, MR was quantified into 5 grades (0 = no 
MR; I = mild; II = mild to moderate; III = moderate; 
IV = severe). Patients were divided into two groups 
according to the presence or absence of MR:
Group I: 20 patients without MR, Group II: 20 
patients with MR.
Patients with trivial MR were included in the 
group without MR. 
Angiographic studies
Coronary angiography was performed to all pa-
tients using standard techniques. Significant coro-
nary disease was defined by angiographic stenosis 
≥70% in the epicardial coronary arteries and ≥50% 
in the left main coronary artery. The extent of coro-
nary disease was characterized by 1-, 2-, or 3-vessel 
disease [17]. Catheterization and percutaneous or 
surgical revascularization were selected according to 
the criteria of the physicians in charge.
Recorded events during follow-up 
The incidence of readmission for heart failure, uns-
table angina, reinfarction, or all combined (ie, the 
combined event or major adverse cardiac event 
[MACE]) was recorded.
Medical events as unstable angina, acute myocar-
dial infarction or heart failure episode that required 
hospital readmission and were noted in the dischar-
ge report as one of the presumed causes of these 
admissions were recorded. Each event was recorded 
only once; for example, after a heart failure event, 
new episodes were not taken into account in the 
statistical analysis of MACEs. For all variables, the 
patient data were censored after the first event.
Statistical analysis
All the analyses were performed using a commer-
cially available software package (IBM SPSS Statistics 
22, USA). Baseline characteristics are expressed as 
mean±standard deviation for continuous variables 
and absolute number (proportions) for categorical 
variables. Comparisons between groups were made 
with Pearson’s x2 test for categorical variables and 
the t-test for continuous variables. In the analysis, 
MR was used as a categorical variable. Long-term 
follow-up survival curves for various groups were 
constructed using the Kaplan–Meier method, and 
comparisons were made using the log-rank test. 
Logistic regression and Cox’s proportional hazards 
regression univariate analysis were used to select 
the variables associated with in-hospital and long-
term events, respectively. 
InternatIonal archIves of MedIcIne
Section: cardiology
Issn: 1755-7682 
2015
Vol. 8 No. 89
doi: 10.3823/1688
This article is available at: www.intarchmed.com and www.medbrary.com 4
A P-value of < 0.05 was considered statistically 
significant [18]. 
Results
Patients characteristics, coronary 
angiography and interventions in the 2 
groups (Table 1)
The study included 40 patients with NSTEMI for the 
1st time. The patients’ mean age was 59.62±10.97 
years and 67.5 % were male.They were divided into 
2 groups according to the presence or absence of 
MR. There was no significant differences between 
the 2 groups regarding age, gender, available risk 
factors, troponin or creatine kinase-MB isoenzymes 
(P > 0.05). Also, no diffirences were found regar-
ding revascularization before getting 1st NSTEMI or 
even after that (P > 0.05), but there was significantly 
increased number of diseased coronary arteries in 
the group of NSTEMI patients with MR (P 0.04). 
Medical treatment at discharge was similar in both 
groups, including ACE-inhibitors, ARBs or B-bloc-
kers (P > 0.05).
Initial echocardiographic parameters in 
the 2 groups (Table 2)
Left atrial diameter was significantly increased in NS-
TEMI patients with MR (P < 0.001). Also, Left ventri-
cular systolic function ( EF%) was decreased in tho-
se patients with MR (P 0.04). The incidence of wall 
motion abnormalities (WMS &WMSI) were greater 
in the group with MR (P < 0.05). No significant di-
fferences between the 2 groups were found regar-
ding left ventricular end systolic and end diastolic 
diameters or transmitral Doppler ultrasound measu-
rements, including E waves, A waves and E/A ratios. 
Also, there was no significant differences between 
the 2 groups regarding systolic pulmonary arterial 
pressure (P > 0.05). 
Follow-up data in the 2 groups (Table 3)
All patients were followed–up for a median of 640.5 
days. No significant difference was found between 
Table 1.  Patients characteristics, coronary angiogra-
phy and interventions.
Parameter
No MR 
(N 20)
MR 
(N 20)
P-value
Age (Y), mean±SD 61.4±11.71 57.85±10.16 0.31
Male, n (%) 13 (65%) 14 (70%) 0.500
Smokers 11 (55%) 12 (60%) 0.500
Hypertension 16 (80 %) 15 (75 %) 0.500
Diabetes melletus 12 (60 %) 13 (65 %) 0.500
Dyslipidemia 14 (70%) 16 (80%) 0.35
Patients with 
previous 
revascularization
5 (25%) 2 (10%) 0.20
Developed Q- wave 
in the acute phase
4 (20%) 6 (30%) 0.35
Peak creatine 
kinase-MB 
20.52±15.93 21.26±17.18 0.88
Peak cardiac 
troponin-I 
5.30±5.42 4.46±4.92 0.61
ACE-inhibitors 
ARBs
14 (70%) 10 (50%) 0.16
Vessel disease 1 (0-2) 1.5 (1-3) 0.04
  1 vessel 13 (65%) 14 (70%) 0.500
  2 vessels 3 (15%) 5 (25%) 0.35
  3 vessels 0 (0%) 1 (5%) 0.500
Patients 
revascularized 
during admittion
15 (75%) 19 (95%) 0.09
ACE:  Angiotensin converting enzyme 
ARBs:  Angiotensin receptor blockers
Table 2. Initial Echocardiographic Parameters.
Parameter
No MR 
(N 20)
MR 
(N 20)
P-value
LAD (cm) 3.33±0.464 4.09±0.675 0.000
ESD (cm) 3.745±0.480 3.925±0.372 0.15
EDD (cm) 5.32±0.698 5.38±0.510 0.73
LVEF % 56.55±6.88 51.85±7.49 0.04
E/A ratio 1.01±0.359 1.09±0.501 0.58
SPAP (mmHg) 24.25±7.188 29.6±11.16 0.08
WMS 18.25±1.45 19.50±1.67 0.016
WMSI 1.14±0.09 1.22±0.10 0.015
LAD: Left atrial diameter, ESD:End systolic diameter, 
EDD: End diastolic diameter, LVEF: Left ventricular ejection 
fraction, SPAP: Systolic pulmonary artery pressure, 
WMS: Wall motion score, WMSI: Wall motion score index 
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the 2 groups regarding the follow-up period (P > 
0.05). Recorded clinical events during follow-up 
period showed more admissions for heart failure 
and unstable angina in patients with MR but did 
not reach statistical significance for heart failure (P 
> 0.05) with little significance for unstable angina 
(p 0.05). 
No differences were observed between both 
groups regarding readmissions for acute myo-
cardial infarction, with or without Q-wave (P > 
0.05). Finally, regarding composite events (MACE), 
a greater incidence was found in the MR group 
(P < 0.05). 
Kaplan-Meier curves and the log-rank test 
showed the long-term association of MACE with 
the presence of MR (p 0.04) (Figure 1), and when 
used to compare long-term prognosis in one 
group without MR or with MR grade I against 
the other group of patients with higher grades 
of MR (≥II), it demonstrated that a higher grades 
of MR were associated with poor prognosis (P 
0.05) (Figure 2). 
The multivariate (cox) analysis was conducted 
and included all variables. WMSI was the only fac-
tor found to be associated with the appearance of 
MACE (HR0.00, 95% CI 1.06–1.19, P 0.01).
Table 3. Follow-up data in the 2 groups.
Parameter
No MR 
(N 20)
MR 
(N 20)
P-value
Follow-up 
period (d)
606.10±227.57 594.10±277.74 0.80
Unstable 
angina
0 (0%) 4 (20%) 0.05
Myocardial 
infarction
2 (10%) 2 (10%) 0.69
Arrythmia 3 (15%) 5 (25%) 0.35
CHF 0 (0%) 2 (10%) 0.24
MACE 2 (10%) 8 (40%) 0.032
CHF :Congestive Heart Failure, MACE: Major Adverse 
Cardiac Events
Figure 1:  Kaplan–Meier survival analysis of MACE-
free survival in NSTEMI patients without 
MR versus with MR.
MACE: major adverse cardiac event, MR: mitral regurgi-
tation, NSTEMI: non- ST-segment elevation myocardial 
infarction.
Figure 2:  Kaplan–Meier survival analysis of MA-
CE-free survival in NSTEMI patients with 
high MR grade versus low MR grade.
MACE: major adverse cardiac event, MR: mitral regurgi-
tation, NSTEMI: non- ST-segment elevation myocardial 
infarction.
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Discussion
Functional ischemic MR is a common finding fo-
llowing acute coronary syndrome [19]. Studies have 
reported its incidence from 9-13% using cardiac 
catheterization [20, 21, 22] to 50% in echocardio-
graphic studies [6, 7, 22]. 
The appearance of mitral regurgitation (MR) in 
the setting of myocardial ischemia could be due to 
discrepancy of tethering force and closing force or 
papillary muscle displacement owing to remodeled 
left ventricle [23].
MR increases LV remodeling and volume in the 
post-MI setting with aggravation of the morpholo-
gical, functional, cellular, and extracellular stigmata 
of remodeling. It can cause as well as result from 
LV remodeling and can therefore potentially exacer-
bate it in a vicious cycle spiraling down to cardiac 
failure unless there is intervention [24, 25]. 
So, detecting and quantifying ischemic mitral re-
gurgitation is necessary since its presence plays an 
essential role in post-MI risk stratification [10].
This study investigate the clinical predictors and 
the prognostic significance of ischemic MR on outco-
me, specifically after a first episode of NSTEMI. Data 
were analyzed from patients who had cardiovas-
cular complications of sufficient clinical severity to 
require re-hospitalization.
The study population was basically homogeneous, 
even in age, sex, smoking and the presence of DM 
and this was discordant with many previous studies 
reported that acute ischemic MR is seen with increa-
sed frequency in elderly, women and nonsmokers 
[7, 20] and this principally may be due to small our 
sample size. 
MR was assessed in all patients during early hos-
pital admission taking into account potential reversi-
ble myocardial dysfunction (stunning or hibernation) 
after infarction which may affect the genesis of MR.
It is well known that MR alone is an independent 
factor of poor prognosis [5, 7, 8, 10] and when 
associated with a myocardial infarction prognosis is 
even worse [5, 8, 10]. 
In our study, a higher rate of composite MACE 
was observed, during follow-up in patients in 
whom ischemic MR was detected in the first echo-
cardiogram during the acute phase of NSTEMI. 
Also, long-term outcome analyses indicated that 
composite MACE was greater in the high grade MR 
group than in the low grade MR group (p 0.05), 
and this was concordant with the study done by 
Grigioni et al, 2001 [6] and Cho et al 2013 [11] 
that showed a graded relationship between MR 
severity and outcome.
There were no significant differences in size 
of the infarction, as measured by creatine kinase 
and troponin I levels, in spite of which LVEF was 
significantly worse in the MR group; may by due 
to increased area of ischemia (stunning) as noted 
by significantly higher WMS and WMSI in the MR 
group. 
Nevertheless, regression analysis revealed that 
WMS and WMSI, not MR, were the only factors 
significantly affect MACE at short and long -term 
outcome, indicating that MR itself was not an in-
dependent predictor of MACE in patients with NS-
TEMI, and MR could be a crude single predictor of 
future adverse cardiac events.
On the other hand, WMSI, a marker of regional 
LV dysfunction, provide powerful prognostic infor-
mation after acute myocardial infarction either at 
short –term or long– term outcome and its pre-
dictive power is even greater than LVEF% [26, 27].
The greater number of diseased vessels in the 
MR group, in addition to being associated with MR, 
could have had an effect on the increased number of 
ischemic events, such as unstable angina, although 
little significance (p 0.05), during follow-up. 
In spite that the role of ischemic MR in the de-
velopment of heart failure after infarction has been 
addressed by many authers [20, 28, 29], there was 
no significant difference between patients with is-
chemic MR and those without regarding the de-
velopment of heart failure during follow up, again, 
may be due to the small sample size in our study. 
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Diastolic function was not specifically explored, 
although some key parameters were analyzed in 
its study, such as left atrial diameter and transmi-
tral peak E and A velocities. The E/A ratio did not 
indicate statistically significant differences between 
the 2 groups. 
For our knowledge, our study may be the 1st 
study to choose patients without MR prior to in-
farction to avoid an additional negative prognostic 
factor and this, on the other hand, affect number 
of patients in the study. 
The limitations of this study would be 1) small 
sample size, 2) lack of echocardiographic follow-
up of MR, 3) no available data to compare the 
effect of early versus late coronary intervention, 4) 
treatment during follow-up was not analyzed, but, 
on the other hand, patients were treated according 
to the norms followed in our institution in recent 
years, and so the results of the study may reflect 
the conditions of daily clinical practice, 5) MR was 
not assessed during coronary angiography.
In conclusion, The presence of MR after a first NS-
TEMI adds prognostic significance to other known 
negative factors. The presence and degree of MR 
confer a worse long-term prognosis to patients af-
ter a first NSTEMI. According to American College 
of Cardiology (ACC)/American Heart Association 
(AHA) guidelines for UA/NSTEMI, initial invasive 
strategy could be indicated in the setting of signs/
symptoms of heart failure or new/worsening mitral 
regurgitation [30]. Thus, the presence of MR should 
be carefully assessed in every patient after an NS-
TEMI, and probably requires even more meticulous 
treatment and stricter follow-up than usual. 
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